Clinical Trials Browser

Phase 2 × Glioma × futuximab × Clear all

NCT02540161 2020-08-05

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

Phase 2 Completed

43 enrolled 14 charts

Glioblastoma, Glioma